Drupal.behaviors.print = function(context) {window.print();window.close();}>
Dx Focus: Cepheid Updates Xpert BCR-ABL Assay; CBLPath Offers NRAS Mutation Test
July 26, 2012
Dx Focus: Cepheid Updates Xpert BCR-ABL Assay; CBLPath Offers NRAS Mutation Test
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Spain's Stat-Diagnostica Aims to Market Near-patient IVD System in Europe, US in 2015
May 16, 2013 / PCR Insider
China's Zeesan Biotech Developing Portfolio of Melt Curve MDx Assays after SFDA Approves TB Tests
April 25, 2013 / PCR Insider
Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider
Cepheid's Q1 Revenues Increase 19 Percent
April 19, 2013 / GenomeWeb Daily News
On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider